{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"3.380","floor":"2.600"},"ipodate":{"start":"2013-10-28 00:00:00","end":"2013-10-31 00:00:00"},"minimumcapital":"--","subscribed":"20.33","marketcap":"50.88億","H_marketcap":"--","pe":"--","codesrate":"80.12","link":"https://staticpdf.iqdii.com/stockdata/notice/Prospectus/01358/LTN20131028016_C.pdf","ipopricing":"3.180","resultdate":"2013-11-07 00:00:00","enddate":"2013-10-31 00:00:00","listeddate":"2013-11-08 00:00:00","issuenumber":"40000.00萬","issuenumberhK":"4000.00萬","issuenumberother":"36000.00萬","grayprice":"--","sponsors":"摩根士丹利亞洲有限公司","raisemoney":"119850.00萬","use":"所得款項凈額約50%或559.2百萬港元用于擴展我們的產能及投資于新產品的研發，包括\n(i)約25%或279.6百萬港元用于購買生產設備\n及完成我們位于北京及山東的新輸液器生產\n廠房的建設；\n(ii)約17%或190.1百萬港元用于拓展我們位于深圳及天津的骨科植入物廠房的產能；\n(iii)約8%或89.5百萬港元投資于新產品的研發；\n\n（2）所得款項凈額約30%或335.5百萬港元用于實\n施我們的擴張計劃，包括作出收購及組件策略聯盟；\n\n（3）所得款項凈額約10%或111.8百萬港元用于擴展我們的分銷網絡及銷售及營銷團隊，包括聘請專注專業的銷售員工；\n（4）其余所得款項凈額最高約10%或111.8百萬港元的任何余額用作額外的營運資金及其他一般企業用途。\n","shares":1000,"leadagent":"摩根士丹利亞洲有限公司","bookrunners":"摩根士丹利亞洲有限公司","coordinator":"摩根士丹利亞洲有限公司","firstDayOpen":"3.18","IsEiio":0,"Interestdays":7,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"摩根士丹利亞洲有限公司","code":"E01358","name":"普華和順","fullname":"普華和順集團公司"},"institutioninfo":{"principaloffice":"中國北京市朝陽區望京阜通東大街6 號方恒國際中心C座1002-1003室","registrars":"卓佳證券登記有限公司","registrarstel":"(852) 2980 1333","chairman":"張月娥","secretary":"黃天宇","telephone":"(8610) 8478 3617","substantialshareholders":"Liu Yufeng(36.65%),陳國泰(26.03%)","principalactivities":"於中國開發、制造及銷售再生醫用生物材料產品；輸液器產品；以及骨科植入物產品。","website":"http://www.pwmedtech.com"},"managerinfo":[],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":520}